Concise review: No breakthroughs for human mesenchymal and embryonic stem cell culture: Conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!

Stem Cells

Volumn 25, Issue 7, 2007, Pages 1603-1609

  Mannello, Ferdinando ^a   Tonti, Gaetana A ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Autologous human serum; Embryonic stem cells; Fetal calf serum; Heterologous human serum; Mesenchymal stem cells; Platelet factor rich supernatant; Serum free medium

Indexed keywords

ALLOIMMUNITY; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL RENEWAL; CELL THERAPY; CELL TRANSPLANTATION; CULTURE MEDIUM; EMBRYONIC STEM CELL; FETAL CALF SERUM; HISTOCOMPATIBILITY; HUMAN; IMMUNITY; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; SHORT SURVEY;

BLOOD SUBSTITUTES; CELL CULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; EMBRYONIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS;

EID: 34547162587     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0127     Document Type: Short Survey

References (89)

1. Sotiropoulou PA, Perez SA, Salagianni M et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. STEM CELLS 2006;24:462-471.
2. Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. New Engl J Med 2006;355:1730-1735.
3. Shahdadfar A, Tronsdal K, Haug T et al. In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. STEM CELLS 2005;23:1357-1366.
4. Berger MG, Veyrat-Masson R, Rapatel C et al. Cell culture medium composition and translational adult bone marrow-derived stem cell research. STEM CELLS 2006;24:2888-2890.
5. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: Paradoxes of passaging. Exp Hematol 2004;32:414-425.
6. Amit M, Shariki C, Margulets V et al. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 2004;70:837-845.
7. Li Y, Powell S, Brunette E et al. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 2005;91:688-698.
8. Moore H. The medium is the message. Nat Biotechnol 2006;24:160-161.
9. Thomson JA, Itskowitz-Eldor J, Saphiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
10. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
11. Smith AG, Heath JK, Donaldson DD et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988;336:688-690.
12. Park JH, Kim SJ, Oh EJ et al. Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biol Reprod 2003;69:2007-2014.
13. Stojkovic P, Lako M, Stewart R et al. An autogenic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. STEM CELLS 2005;23:306-314.
14. Information and recommendations for physicians involved in the coculture of human embryos with nonhuman animal cells. Food and Drug Administration Web site. Available at: http://www.fda.gov/cber/infosheets/humembclin.htm. Accessed March 5, 2007.
15. Lim JW, Bodnar A. Proteome analysis of conditioned medium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells. Proteomics 2002;2:1187-1203.
16. Xu RH, Peck RM, Li DS et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2005;2:185-190.
17. Richards M, Tan S, Fong CY et al. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. STEM CELLS 2003;21:546-556.
18. Hovatta O, Mikkola M, Gertow K et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 2003;18:1404-1409.
19. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19:971-974.
20. Klimanskaya I, Chung Y, Meisner L et al. Human embryonic stem cells derived without feeder cells. Lancet 2005;365:1636-1641.
21. Niwa H, Burdon T, Chambers I et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998;12:2048-2060.
22. Conover JC, Ip NY, Poueymirou WT et al. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development 1993;119:559-565.
23. Xu C, Rosler E, Jiang J et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. STEM CELLS 2005;23:315-323.
24. Lutolf MP, Hubbell JA. Synthetic biomaterial as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005;23:47-55.
25. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-1910.
26. Martin MJ, Muotri A, Gage F et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005;11:228-232.
27. Heiskanen A, Satomaa T, Tiitinen S et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. STEM CELLS 2007;25:197-202.
28. Skottman H, Stromberg AM, Matilainen E et al. Unique gene expression signature by human embryonic stem cells cultured under serum-free conditions correlates with their enhanced and prolonged growth in an undifferentiated stage. STEM CELLS 2006;24:151-167.
29. Stojkovic P, Lako M, Przyborski S et al. Human-serum matrix supports undifferentiated growth of human embryonic stem cells. STEM CELLS 2005;23:895-902.
30. Rajala K, Hakala H, Panula S et al. Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod 2007 (in press).
31. Imreh MP, Gertow K, Cedervall J et al. In vitro culture conditions favouring selection of chromosomal abnormalities in human ES cells. J Cell Biochem 2006;99:508-516.
32. Tolar J, Nauta AJ, Osborn MJ et al. Sarcoma derived from cultured mesenchymal stem cells. STEM CELLS 2007;25:371-379.
33. Honn KV, Singley JA, Chavin W. Fetal bovine serum: A multivariate standard. Proc Soc Exp Biol Med 1975;149:344-347.
34. Zheng X, Baker H, Hancock WS et al. Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs. Biotechnol Prog 2006;22:1294-1300.
35. Spees JL, Gregory CA, Singh H et al. Internalized antigen must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004;9:747-756.
36. Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting. Bull World Health Organ 1997;75:505-513.
37. Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocytes infusions. Blood 1997;89:776-779.
38. Chachques JC, Herreros J, Trainini J et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillator in cellular cardiomyoplasty. Int J Cardiol 2004;95(suppl 1):S29-S33.
39. Chen SJ, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
40. Katritsis DG, Sotiropoulou PA, Karvouni E et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005;65:321-329.
41. Tuschong L, Soenen SL, Blaese RM et al. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002;13:1605-1610.
42. Hung CH, Young TH. Differences in the effect on neural stem cells of fetal bovine serum in substrate-coated and soluble form. Biomaterials 2006;27:5901-5908.
43. Bruinink A, Tobler U, Halg M et al. Effects of serum and serum heat-inactivation on human bone derived osteoblast progenitor cells. J Mater Sci Mater Med 2004;15:497-501.
44. Haylett AK, Moore JV. Comparative analysis of foetal calf and human low density lipoprotein: Relevance for pharmacodynamics of photosensitizers. J Photochem Photobiol B 2002;66:171-178.
45. Sypniewska G, Xu XF, Hager A et al. Effects of age, obesity and growth-hormone on adipogenic activity in human plasma. Int J Obes 1987;11:263-273.
46. Menon S, Isenberg DA. Foetal calf serum in growth medium obscures the detection of early anticardiolipin antibody secreting clones. J Immunol Methods 1995;186:65-70.
47. Shields MJ, Moffat LE, Ribaudo RK. Functional comparison of bovine, murine, and human beta2-microglobulin: Interactions with murine MHC I molecules. Mol Immunol 1998;35:919-928.
48. Dictus C, Tronnier V, Unterberg A et al. Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J Neurosci Methods 2007;161:250-258.
49. Nie Z. Fetuin: Its enigmatic property of growth promotion. Am J Physiol 1992;263:C551-C562.
50. Brown WM, Saunders NR, Mollgard K et al. Fetuin - an old friend revisited. Bioessays 1992;14:749-755.
51. Kubler D, Gosenca D, Wind M et al. Proteolytic processing by matrix metalloproteinases and phosphorylation by protein kinase CK2 of fetuin-A, the major globulin of fetal calf serum. Biochimie 2007;89:410-418.
52. Mannello F, Tonti GA, Bagnara GP et al. Role and function of matrix metalloproteinases in the differentiation and biological characterisation of mesenchymal stem cells. STEM CELLS 2006;24:475-481.
53. Mannello F. Multipotent mesenchymal stromal cell recruitment, migration, and differentiation: What have matrix metalloproteinases got to do with it? STEM CELLS 2006;24:1904-1907.
54. Dimarakis I, Levicar N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. STEM CELLS 2006;24:1407-1408.
55. Sekiya I, Larson BL, Smith JR et al. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. STEM CELLS 2002;20:530-541.
56. Sotiropoulou PA, Perez SA, Salagianni M et al. Cell culture medium composition and translational adult bone marrow-derived stem cell research. STEM CELLS 2006;24:1409-1410.
57. Kume T, Taguchi R, Katsuki H et al. Serofendic acid, a neuroprotective substance derived from fetal calf serum, inhibit mitochondrial depolarization and caspase-3 activation. Eur J Pharmacol 2006;542:69-76.
58. Bernardo ME, Avanzini MA, Perotti C et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for celltherapy approaches: Further insight in the search for a fetal calf serum substitute. J Cell Physiol 2007;211:121-130.
59. Caterson EJ, Nesti LJ, Danielson KG et al. Human marrow-derived mesenchymal progenitor cells: Isolation culture, expansion and analysis of differentiation. Mol Biotechnol 2002;20:245-256.
60. Draper JS, Moore HD, Ruban NN et al. Culture and characterisation of human embryonic stem cells. Stem Cells Dev 2004;13:325-336.
61. Skottman H, Dilber MS, Hovatta O. The derivation of clinical grade human embryonic stem cell lines. FEBS Lett 2006;580:2875-2878.
62. Oreffo RO, Virdi AS, Triffitt JT. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 1997;74:251-261.
63. Yamamoto N, Isobe M, Negishi A et al. Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J Med Dent Sci 2003;50:63-69.
64. Stute N, Holtz K, Bubenheim M et al. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004;32:1212-1225.
65. Lin HT, Tarng YW, Chen YC et al. Using human plasma supplemented medium to cultivated human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant Proc 2005;37:4504-4505.
66. Kobayashi T, Watanabe H, Yanagawa T et al. Motility and growth of human bone-marrow mesenchymal stem cells during ex-vivo expansion in autologous serum. J Bone Joint Surg Br 2005;87:1426-1433.
67. Gregory CA, Reyes E, Whitney MJ et al. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogeneic species-specific serum and administration in fibrin constructs. STEM CELLS 2006;24:2232-2243.
68. Mizuno N, Shiba H, Ozeki Y et al. Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int 2006;30:521-524.
69. Yamaguchi M, Hirayama F, Wakamoto S et al. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cell expansion. Transfusion 2002;42:921-927.
70. Anselme K, Broux O, Noel B et al. In vitro control of human bone marrow stromal cells for bone tissue engineering. Tissue Eng 2002;8:941-953.
71. Kuznetsov SA, Mankani MH, Robey PG. Effect of serum on human bone marrow stromal cells: Ex vivo expansion and in vivo bone formation. Transplantation 2000;70:1780-1787.
72. Muller I, Kordowich S, Holzwarth C et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006;8:437-444.
73. Kilian O, Flesch I, Wenisch S et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 2004;9:337-344.
74. Gruber R, Karreth F, Kandler B et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitors cells under in vitro conditions. Platelets 2004;15:29-35.
75. Doucet C, Ernou I, Zhang Y et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005;205:228-236.
76. Vogel JP, Szalay K, Geiger F et al. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 2006;17:462-469.
77. Kocaoemer A, Kern S, Klueter H et al. Human AB-serum as well as thrombin-activated platelet-rich-plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. STEM CELLS 2007;25:1270-1278.
78. Lee JB, Lee JE, Park JH et al. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod 2005;72:42-49.
79. Amit M, Itskovitz-Eldor J. Feeder-free culture of human embryonic stem cells. Methods Enzymol 2006;420:37-49.
80. Hong-mei P, Gui-an C. Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Hum Reprod 2006;21:217-222.
81. Chen HF, Kuo HC, Chien CL et al. Derivation, characterization and differentiation of human embryonic stem cells: Comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Hum Reprod 2007;22:567-577.
82. Wong RC, Dottori M, Koh KL et al. Gap junctions modulate apoptosis and colony growth of human embryonic stem cells maintained in a serum-free system. Biochem Biophys Res Commun 2006;344:181-188.
83. Liu CH, Wu ML, Hwang SM. Optimization of serum free medium for cord blood mesenchymal stem cells. Biochem Eng J 2007;33:1-9.
84. Pochampally RR, Smith JR, Ylostalo J et al. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 2004;103:1647-1652.
85. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 1995;85:929-940.
86. Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 1997;97:561-570.
87. Foreman MA, Smith J, Publicover SJ. Characterisation of serum-induced intracellular Ca2+ oscillations in primary bone marrow stromal cells. J Cell Physiol 2006;206:664-671.
88. Zhu W, Chen J, Cong X et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. STEM CELLS 2006;24:416-425.
89. Mimeault M, Batra SK. Concise review: Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. STEM CELLS 2006;24:2319-2345.